SM
OXFD

Senvest Management’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Senvest Management’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,470,593
Closed -$25.7M – 106
2020
Q4 		$25.7M Buy
1,470,593
+134
+0% +$1.88K 1% 28
2020
Q3 		$17.2M Buy
1,470,459
+14,000
+1% +$186K 0.98% 29
2020
Q2 		$18.9M Buy
1,456,459
+130,605
+10% +$1.57M 1.18% 24
2020
Q1 		$12.3M Buy
1,325,854
+626,469
+90% +$8.75M 1.44% 16
2019
Q4 		$11.6M Buy
699,385
+94,353
+16% +$1.53M 0.79% 20
2019
Q3 		$10.1M Buy
605,032
+114,130
+23% +$1.58M 0.87% 22
2019
Q2 		$6.75M Buy
490,902
+120,329
+32% +$1.84M 0.59% 23
2019
Q1 		$6.38M Buy
+370,573
New +$5.86M 0.48% 30

Senvest Management's OXFD Position: Q1 2021 in Review

Senvest Management sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q1 2021, closing a stake of 1,470,593 shares — an estimated $25.7M sold.

Senvest Management first reported a position in OXFD in Q1 2019 and held it in 8 quarters. The position peaked at $25.7M in Q4 2020. 0 funds tracked by Wall St. Rank hold OXFD as of Q1 2021.

  • Senvest Management reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q1 2021 after selling out during the quarter.
  • Senvest Management sold 1,470,593 Oxford Immunotec Global PLC Ordinary Shares shares in Q1 2021, an estimated $25.7M.
  • Senvest Management first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q1 2019 and held it in 8 quarters.
  • Senvest Management's Oxford Immunotec Global PLC Ordinary Shares position peaked at $25.7M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q1 2021.

Based on Senvest Management's 13F filing for Q1 2021, filed 14 May 2021.